Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
203.1 EUR | -0.64% | -1.36% | -15.20% |
Apr. 23 | SARTORIUS STEDIM BIOTECH : Barclays reaffirms its Neutral rating | ZD |
Apr. 22 | Sartorius Stedim: in the red with brokerage comments | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.20% | 21.38B | |
-4.66% | 183B | |
-1.01% | 108B | |
-4.20% | 67.51B | |
+2.68% | 50.67B | |
+9.12% | 44.7B | |
+2.41% | 40.95B | |
+4.13% | 26.71B | |
+3.31% | 26.8B | |
+12.66% | 24.62B |
- Stock Market
- Equities
- DIM Stock
- News Sartorius Stedim Biotech
- UBS Cuts Sartorius Stedim Biotech PT, Maintains at Neutral